# Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/treatment-patterns-and-overall-survival-of-patients-with-double-class-and-triple/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter Feng Wang,Christopher Yee,Boris Gorsh,Miriam L. Zichlin,Prani Paka,Rachel H. Bhak,Natalie Boytsov,Anamika Khanal,Ahmed Noman,Maral DerSarkissian,Shannon Ferrante,Mei Sheng Duh |
| Citations | 35 |
| DOI | 10.1080/10428194.2022.2140284 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1080/10428194.2022.2140284 |
| OpenAlex ID | https://openalex.org/W4309506283 |
| PMID | 36408998 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Natalie Boytsov](https://scholariq.org/researchers/natalie-boytsov/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.